Slit2/Robo1 signaling inhibits small‐cell lung cancer by targeting β‐catenin signaling in tumor cells and macrophages-Reference-Cited by-同舟云学术

Slit2/Robo1 signaling inhibits small‐cell lung cancer by targeting β‐catenin signaling in tumor cells and macrophages

Published:2023-01-10 Issue:5 Volume:17 Page:839-856
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Ahirwar Dinesh K.¹²³,Peng Bo¹,Charan Manish¹,Misri Swati¹,Mishra Sanjay¹,Kaul Kirti¹,Sassi Salha¹,Gadepalli Venkat Sundar⁴,Siddiqui Jalal²⁵,Miles Wayne O.²⁵,Ganju Ramesh K.¹²^ORCID

Affiliation:

1. Department of Pathology, College of Medicine The Ohio State University Columbus OH USA

2. Comprehensive Cancer Center The Ohio State University Columbus OH USA

3. Department of Bioscience & Bioengineering Indian Institute of Technology Jodhpur India

4. Biomedical Informatics The Ohio State University Columbus OH USA

5. Department of Cancer Biology and Genetics The Ohio State University Columbus OH USA

Funder

National Cancer Institute

U.S. Department of Defense

Comprehensive Cancer Center, City of Hope

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13289

Reference86 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Unravelling the biology of SCLC: implications for therapy

3. Specific organ metastases and survival in small cell lung cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alveolar type 2 cells marker gene SFTPC inhibits epithelial-to-mesenchymal transition by upregulating SOX7 and suppressing WNT/β-catenin pathway in non-small cell lung cancer;Frontiers in Oncology;2024-09-13

2. Research advances on signaling pathways regulating the polarization of tumor-associated macrophages in lung cancer microenvironment;Frontiers in Immunology;2024-07-31

3. The genomic landscape of the immune system in lung cancer: present insights and continuing investigations;Frontiers in Genetics;2024-06-25

4. Glycogen synthase kinase-3: A potential immunotherapeutic target in tumor microenvironment;Biomedicine & Pharmacotherapy;2024-04

5. High-accuracy prediction of colorectal cancer chemotherapy efficacy using machine learning applied to gene expression data;Frontiers in Physiology;2024-01-18